Neuberger Berman Group LLC Moderna, Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 87,501 shares of MRNA stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,501

Previous 254,821 65.66%

Holding current value

$3.22 Million

Previous $30.3 Million 80.68%

% of portfolio

0.0%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $10.6 Million - $20.9 Million	-167,320 Reduced 65.66%	87,501 $5.85 Million
Q2 2024 Nov 14, 2024	BUY	$101.21 - $166.61 $6.71 Million - $11 Million	66,267 Added 35.14%	254,821 $30.3 Million
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $6.71 Million - $11 Million	66,267 Added 35.14%	254,821 $30.3 Million
Q1 2024 Nov 14, 2024	BUY	$85.37 - $115.44 $5.29 Million - $7.15 Million	61,911 Added 48.89%	188,554 $20.1 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $16.1 Million - $21.8 Million	188,554 New	188,554 $20.1 Million
Q4 2023 Nov 14, 2024	SELL	$69.51 - $104.43 $8.91 Million - $13.4 Million	-128,178 Reduced 50.3%	126,643 $12.6 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $600,635 - $902,379	8,641 Added 7.32%	126,643 $12.6 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $3.5 Million - $4.6 Million	36,293 Added 44.42%	118,002 $12.2 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $1.68 Million - $2.28 Million	14,216 Added 21.06%	81,709 $9.93 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $619,287 - $899,396	4,565 Added 7.25%	67,493 $10.4 Million
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $507,731 - $900,861	4,289 Added 7.31%	62,928 $11.3 Million
Q3 2022 Nov 15, 2022	SELL	$118.07 - $194.18 $219,846 - $361,563	-1,862 Reduced 3.08%	58,639 $6.94 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $3.13 Million - $4.73 Million	26,761 Added 79.32%	60,501 $8.65 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $208,532 - $387,597	1,649 Added 5.14%	33,740 $5.35 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $6.09 Million - $9.94 Million	-26,983 Reduced 45.68%	32,091 $7.71 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $1.2 Million - $2.62 Million	-5,407 Reduced 8.39%	59,074 $22 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $3.89 Million - $7.04 Million	29,981 Added 86.9%	64,481 $15 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $2.39 Million - $4.06 Million	21,845 Added 172.62%	34,500 $4.5 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $10.4 Million - $26.9 Million	-158,500 Reduced 92.61%	12,655 $1.31 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $2.54 Million - $4.43 Million	46,679 Added 37.5%	171,155 $12.1 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $118,323 - $319,040	3,988 Added 3.31%	124,476 $7.99 Million
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $9.24 Million - $16.4 Million	-519,718 Reduced 81.18%	120,488 $3.61 Million
Q4 2019 Feb 12, 2020	BUY	$13.93 - $21.28 $2,786 - $4,256	200 Added 0.03%	640,206 $12.5 Million
Q3 2019 Nov 13, 2019	SELL	$12.26 - $18.07 $9.17 Million - $13.5 Million	-748,108 Reduced 53.89%	640,006 $10.2 Million
Q2 2019 Aug 13, 2019	BUY	$13.7 - $28.34 $9.36 Million - $19.4 Million	683,159 Added 96.91%	1,388,114 $20.3 Million
Q1 2019 May 13, 2019	SELL	$14.45 - $23.7 $3.5 Million - $5.74 Million	-242,070 Reduced 25.56%	704,955 $14.3 Million
Q4 2018 Feb 12, 2019	BUY	$13.52 - $18.8 $12.8 Million - $17.8 Million	947,025 New	947,025 $14.5 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Moderna, Inc. Transaction History